TCF1+PD-1+ tumour-infiltrating lymphocytes predict a favorable response and prolonged survival after immune checkpoint inhibitor therapy for non-small-cell lung cancer

Jaemoon Koh, Sehui Kim, Yeon Duk Woo, Seung Geun Song, Jeemin Yim, Bogyeong Han, Sojung Lim, Hyun Kyung Ahn, Seungchan Mun, Jung Sun Kim, Bhumsuk Keam, Young A Kim, Se‐Hoon Lee, Yoon Kyung Jeon, Doo Hyun Chung